News

scynexis picture

SCYNEXIS CEO Cites New Jersey’s Ideal Location, Resources as Key to Company’s Goal of Bringing New Anti-Fungal Treatment to Patients

TRENTON, N.J. (January 16, 2019) – When Dr. Marco Taglietti became Chief Executive Officer of SCYNEXIS, Inc. (NASDAQ: SCYX) in April 2015, he knew that he wanted to move the publicly-traded biopharmaceutical company from North Carolina to

SCYNEXIS CEO Cites New Jersey’s Ideal Location, Resources as Key to Company’s Goal of Bringing New Anti-Fungal Treatment to Patients Read More »

Scroll to Top